Working… Menu

Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, ALCHEMIST Chemo-IO Study

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT04267848
Recruitment Status : Recruiting
First Posted : February 13, 2020
Last Update Posted : July 12, 2021
Information provided by (Responsible Party):
National Cancer Institute (NCI)